Business Description

Description
Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product name VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.
Name Current Vs Industry Vs History
Cash-To-Debt 0.18
Equity-to-Asset -6.41
Debt-to-Equity -0.23
Debt-to-EBITDA -0.43
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 39
3-Year EPS without NRI Growth Rate 42.5
3-Year FCF Growth Rate 54.5
Name Current Vs Industry Vs History
5-Day RSI 64.78
9-Day RSI 45.37
14-Day RSI 37.11
6-1 Month Momentum % -26
12-1 Month Momentum % 122

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.13
Quick Ratio 0.13
Cash Ratio 0.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.3
Name Current Vs Industry Vs History
ROA % -488.69
ROIC % -220.26

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -43.46
EV-to-EBITDA -43.88
EV-to-FCF -60.66
Earnings Yield (Greenblatt) % -2.3
FCF Yield % -1.06

Financials (Next Earnings Date:2024-05-15 Est.)

VICP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:VICP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vicapsys Life Sciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.034
Beta 2.6
Volatility % 179.76
14-Day RSI 37.11
14-Day ATR ($) 0.09289
20-Day SMA ($) 1.19845
12-1 Month Momentum % 122
52-Week Range ($) 0.6 - 3
Shares Outstanding (Mil) 32.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vicapsys Life Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Vicapsys Life Sciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Vicapsys Life Sciences Inc Frequently Asked Questions

What is Vicapsys Life Sciences Inc(VICP)'s stock price today?
The current price of VICP is $0.98. The 52 week high of VICP is $3.00 and 52 week low is $0.60.
When is next earnings date of Vicapsys Life Sciences Inc(VICP)?
The next earnings date of Vicapsys Life Sciences Inc(VICP) is 2024-05-15 Est..
Does Vicapsys Life Sciences Inc(VICP) pay dividends? If so, how much?
Vicapsys Life Sciences Inc(VICP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1